Beijing Boren Hospital
Clinical trials sponsored by Beijing Boren Hospital, explained in plain language.
-
Could a single infusion of modified immune cells tame stubborn autoimmune diseases?
Disease control Recruiting nowThis early study is testing a new treatment for people with autoimmune diseases like lupus, scleroderma, and multiple sclerosis that haven't improved with standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to target and calm the overa…
Phase: PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated May 17, 2026 16:21 UTC
-
New injection aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new drug, AFN50, in 18 adults with autoimmune diseases that haven't responded to other treatments. The main goal is to check if the drug is safe and tolerable. Researchers will also measure how long special immune cells (CAR T cells) stay in the blo…
Phase: EARLY_PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Engineered immune cells take on Hard-to-Treat brain cancer
Disease control Recruiting nowThis early-phase study tests a personalized therapy where a patient's own immune cells are modified to recognize and attack lymphoma cells in the brain. It is for people aged 18-75 with central nervous system lymphoma that has relapsed or not responded to prior treatments. The go…
Phase: PHASE1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC